Genmab — Oktober 2025

[E_L]

fallbacks so far are very benign... if we could range / stabilise a bit here around this 2100 level and make a nice base for the next rise EL would be very happy

[E_L]

Targeted Therapy Offers Hope for Metastatic Cervical Cancer https://blog.dana-farber.org/insight/2025/10/targeted-therapy-offers-hope-cervical-cancer/

[bikube]

Thanks for the story E L, it´s nearly unbelievale, but fantastic.

[E_L]

Petosemtamab shows first colorectal promise https://www.oncologypipeline.com/apexonco/petosemtamab-shows-first-colorectal-promise

[E_L]

teclistamab - Myeloma Drug Performs Well in Autoimmune Diseases https://www.medpagetoday.com/rheumatology/generalrheumatology/117966

[E_L]

TECVAYLI plus DARZALEX FASPRO combination regimen significantly
improves progression-free survival and overall survival versus standard of care https://www.jnj.com/media-center/press-releases/tecvayli-plus-darzalex-faspro-combination-regimen-significantly-improves-progression-free-survival-and-overall-survival-versus-standard-of-care

[E_L]

• At almost three years follow-up, the combination of TECVAYLI and DARZALEX FASPRO met the primary endpoint of progression-free survival (PFS) - Independent Data Monitoring Committee (IDMC) recommended unblinding the study based on statistically significant results

[E_L]

J&J claims a Tecvayli/Darzalex combo win https://www.oncologypipeline.com/apexonco/jj-claims-tecvaylidarzalex-combo-win

[ProinvestorNEWS]

Genmab-partner viser bedre overlevelsesmuligheder for kræftsyge i kombinationsstudie https://proinvestor.com/investornyt/1371488/genmab-partner-viser-bedre-overlevelsesmuligheder-for-kraeftsyge-i-kombinationsstudie

[bikube]

Måske derfor de ikke ville købe "Superdara".

[Elmer]

Her en vurdering med hjælp fra copilot med info fra Proinvestor. Hvis Tecvayli/Darzalex bliver en ny SOC i relapsede/refraktære myelom-patienter, kan royalty-strømmen blive en vigtig vækstdriver for Genmab – især hvis Darzalex fortsætter sin blockbuster-status og Tecvayli bliver en fast del af regimet.

[JKY_VH]

Aktiespararna ger köpråd för Genmab. "Aktien har stigit en del under hösten men med höjda prognoser och ett
lovande förvärv ser vi fortsatt potential. Rådet blir köp med riktkurs 2.500 danska kronor", skriver Aktiespararna.

[Raun]

Det er voldsomt, så ustabil kursen har været den seneste tid

[Sukkeralf]

Det er nok snarere sektoren der er ustabil

[Aps_invest]

Vel bare ligeså ustabil som resten af markedet p.t

[bibob]

Markedet svinger med Trumpeten.

[ProinvestorNEWS]

Aktier: Er det korrektionstid? https://proinvestor.com/boards/128988

[E_L]

earlier Interview Jan van de Winkel: keynote speaker of the 2025 Utrecht Science Lecture. https://www.utrechtsciencepark.nl/en/about/view/stories-interviews/interview-jan-van-de-winkel-keynote-opening-utrecht-science-week-september-26

[E_L]

One of the first ESMO sessions , Rinatabart mentioned https://x.com/omalirp/status/1979131841329197409/photo/1

[Raun]

Argh, jeg synes nu godt noka t Venmab er i en liga for sig. Når vi snakker om ustabil kurs.... men en flot comeback, og nu på vej ned igen...